Auto Lease Compare is a company that uses a web-based platform to provide business services of leasing cars in the UK market. The company is on a mission to transform the growing UK car leasing industry. They are currently operating in a leasing & rental market worth £49 billion in the UK alone. Auto Lease Compare have increased their users to 40,000 on the platform and have also partnered with some of the UK’s leading leasing companies. With the investment, the company will grow its business by revamping and upgrading the website, executing a strong marketing strategy and increasing brand awareness.
days to go:
Expired
investment:
£111,860
Veluba is a zero-emission transport solution for London. It is an application-hailed and pedal-powered eco-cab service for Central London which aims to provide a faster and cheaper solution for its over-polluted and over-congested capital city. The company has 30 Veluba cabs ready to go with and have just launched their app. The vehicles are designed and driven with safety at the forefront and drivers are fully insured. Each Veluba® is provided with digital signage screens, giving prominent ad space, and the possibility for an additional revenue stream. Veluba aims to expand beyond the first depot to reach more of London and become a key part of the city’s growing eco-transport infrastructure. The investment will enable the company to employ additional drivers.
days to go:
Expired
investment:
£78,590
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
Boundless Labs' Moodspace is an online learning platform for mental health treatment. It was commenced as a passion project between friends in 2014 later evolving into an application. The company takes established concepts from mental health therapy and re-imagines this teaching for a digital world, as daily mental health workouts. The platform has 5,400 monthly active members as of January 2020. Moodspace aims to teach the full breadth of therapy and empowers everyone to take control of their mental health. With the proceeds, the company will curate a wider breadth of mental health concepts and cultivate partnerships within the mental health ecosystem that includes building B2B relationships directly with therapists.
days to go:
Expired
investment:
£55,710
Nutrifix is an app that locates healthy meals nearby or selects recipes or delivery options all tailored to you bodies needs. The app is like having a personal nutritionist in your pocket and is in a growing sector as the global value of mobile health solutions is set to reach 83,000,000,000 by 2022.
days to go:
Expired
investment:
£194,310
Try EV is a platform that allows customers to discover, analyze, customize and explore with EVs before making a final buying decision. It encourages “electrify to buy” and intends to change the car purchasing process. The company has also collaborated with big brands such as BMW, Tesla, etc. Try Ev was an Exhibitor at London Motor Show 2019, it was shortlisted for “Greener Greenwich” at Greenwich Business Awards and it was an Elevator Pitch Business Awards finalists at London Motor Show 2018. The funds will be used to balance the growth, to bring key talent, to promote partnerships with major leasing companies and charging networks and to improve marketing and promotion efforts.
days to go:
Expired
investment:
£88,430
BioScore is a London-based health technology platform that enables you to easily visualize, track, and understand your fitness and health test results. It is currently designed as a software service for health and fitness professionals, gyms, personal trainers, sports coaches, sports clubs, schools, other allied health consultants and their clients. Leveraging on the trend of health optimization, BioScore aims to provide meaningful infographics and explanations, linked test histories, and personalised advice and action plans from fitness or health experts to their respective end-users, resulting in more effective diagnosis of ailments. The company will utilise the investment to develop an athlete management platform with an inspiring infographic, reporting and sell licences to access the platform's suite of online tools.
days to go:
Expired
investment:
£57,580
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap.
days to go:
Expired
investment:
£199,227
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Studio Pictures Limited is a UK based production company that specialises in the development of high-quality British film and TV projects. The company's interest predominantly lies within the British film and television industry that can be created within budget ranging from £1 million - £15 million. The company has established relationships with studio houses such as Warner Bros., Sony Pictures and Lionsgate and aims to build upon projects that can be made into a franchise. Their production, A Steet Cat Named Bob, went on to be distributed by Sony Pictures in the UK and had a Royal Premiere in London. Studio Pictures Limited will consider putting up to a maximum of 20% of the budget for each project as equity, on a case by case basis, subject to company reserves. With the proceeds, the company will grow and scale the business. It will become a tenant at Twickenham Studios in West London and look to profitable emerging markets, i.e. streaming, animation and interactive movies to become one of the leading UK production companies.
days to go:
Expired
investment:
Withheld
